Activist 13D/13G Filings - Nuvectis Pharma Inc. (NVCT)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-28
08:37 am
Purchase
13GNUVECTIS PHARMA INC
NVCT
Mosseri Marlio Charles2,595,000
15%
214,824increase
(+9.03%)
View
2024-02-06
08:47 am
Purchase
13GNUVECTIS PHARMA INC
NVCT
Pontifax Management 4 G.P. (2015) Ltd.917,400
5.3%
917,400increase
(New Position)
View
2024-01-31
7:34 pm
Purchase
13GNUVECTIS PHARMA INC
NVCT
Poradosu Enrique1,503,819
8.7%
285,500increase
(+23.43%)
View
2024-01-31
7:33 pm
Purchase
13GNUVECTIS PHARMA INC
NVCT
Shemesh Shay1,491,955
8.6%
286,090increase
(+23.72%)
View
2024-01-30
9:01 pm
Sale
13GNUVECTIS PHARMA INC
NVCT
Peters Thomas Phineas908,475
5.2%
-39,183decrease
(-4.13%)
View
2023-04-03
08:15 am
Purchase
13GNUVECTIS PHARMA INC
NVCT
Peters Thomas Phineas947,658
6.4%
947,658increase
(New Position)
View
2023-02-13
5:16 pm
Purchase
13GNUVECTIS PHARMA INC
NVCT
Shemesh Shay1,205,865
8.2%
1,205,865increase
(New Position)
View
2023-02-13
5:15 pm
Purchase
13GNUVECTIS PHARMA INC
NVCT
Poradosu Enrique1,218,319
8.3%
1,218,319increase
(New Position)
View
2023-01-09
10:19 am
Purchase
13GNUVECTIS PHARMA INC
NVCT
Mosseri Marlio Charles2,380,176
16.3%
977,620increase
(+69.70%)
View
2022-03-28
6:46 pm
Purchase
13GNUVECTIS PHARMA INC
NVCT
Mosseri Marlio Charles1,402,556
11.03%
1,402,556increase
(New Position)
View
2022-03-28
5:22 pm
Purchase
13DNUVECTIS PHARMA INC
NVCT
BENTSUR RON2,728,700
21.46%
2,728,700increase
(New Position)
View
2022-02-15
5:18 pm
Purchase
13GNUVECTIS PHARMA INC
NVCT
Mosseri Marlio Charles1,265,200
9.95%
1,265,200increase
(New Position)
View